Deorphanization of Novel Peptides and Their Receptors

Journal Title: The AAPS Journal - Year 2010, Vol 12, Issue 3

Abstract

Peptide hormones and neuropeptides play important roles in endocrine and neural signaling, often using G protein-coupled receptor (GPCR)-mediated signaling pathways. However, the rate of novel peptide discovery has slowed dramatically in recent years. Genomic sequencing efforts have yielded a large number of cDNA sequences that potentially encode novel candidate peptide precursors, as well as hundreds of orphan GPCRs with no known cognate ligands. The complexity of peptide signaling is further highlighted by the requirement for specific posttranslational processing steps, and these must be accomplished in vitro prior to testing newly discovered peptide precursor candidates in receptor assays. In this review, we present historic as well as current approaches to peptide discovery and GPCR deorphanization. We conclude that parallel and combinatorial discovery methods are likely to represent the most fruitful avenues for both peptide discovery as well as for matching the remaining GPCRs with their peptide ligands.

Authors and Affiliations

Akihiko Ozawa, Iris Lindberg, Bryan Roth, Wesley K. Kroeze

Keywords

Related Articles

Preclinical Pharmacokinetic/Pharmacodynamic Modeling and Simulation in the Pharmaceutical Industry: An IQ Consortium Survey Examining the Current Landscape

The application of modeling and simulation techniques is increasingly common in preclinical stages of the drug discovery and development process. A survey focusing on preclinical pharmacokinetic/pharmacodynamics (PK/PD)...

Elastic Liposomal Formulation for Sustained Delivery of Colchicine: In Vitro Characterization and In Vivo Evaluation of Anti-gout Activity

Colchicine, an alkaloid found in extracts of the plants Colchicum autumnale and Gloriosa superb, is effective in the treatment of acute gout and dermatological conditions like leuko-cytoclastic vasculitis, psoriasis, and...

Synthesis and characterization of positively charged tPA as a prodrug using a heparin/protamine-based drug-delivery system

Positively charged peptides [(Arg)-Cys] were sucessfully linked to tissue-specific plasminogen activator (tPA) using cross-linking agent N-succinimidyl 3-(2-pyridyldithio) propionate. Specific amidolytic activity of this...

Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars?

CT-P13, the world’s first biosimilar monoclonal antibody to infliximab, was approved for marketing in South Korea for all the six indications of infliximab, which Europe may follow, although the product was teste...

Conformational Analysis of Therapeutic Proteins by Hydroxyl Radical Protein Footprinting

The online version of this article (doi:10.1208/s12248-012-9336-7) contains supplementary material, which is available to authorized users.

Download PDF file
  • EP ID EP681401
  • DOI  10.1208/s12248-010-9198-9
  • Views 61
  • Downloads 0

How To Cite

Akihiko Ozawa, Iris Lindberg, Bryan Roth, Wesley K. Kroeze (2010). Deorphanization of Novel Peptides and Their Receptors. The AAPS Journal, 12(3), -. https://europub.co.uk/articles/-A-681401